Review
doi: 10.1007/BF01987953.
Chronic obstructive pulmonary disease and asthma. General and medical management with special attention to exacerbations
Affiliations
- PMID: 2677981
- DOI: 10.1007/BF01987953
Item in Clipboard
Review
Chronic obstructive pulmonary disease and asthma. General and medical management with special attention to exacerbations
Pharm Weekbl Sci.
.
Abstract
The general management of patients with chronic obstructive pulmonary disease and asthma is discussed. Pathophysiological mechanisms of bronchial obstruction and inflammation are briefly described. The importance of preventive measures is emphasized. Medicine prescribed in chronic obstructive pulmonary disease and asthma, their relative place in treatment schedules and route of administration are reviewed. Finally, the importance of maximal bronchodilatation in exacerbations is stressed and the few indications for antibiotic treatment are discussed.
Similar articles
-
Comparison of the bronchodilator activities of oxitropium bromide, fenoterol, and their combination in patients with chronic obstructive pulmonary disease and bronchial asthma.Clin Auton Res. 1993 Feb;3(1):41-4. doi: 10.1007/BF01819142. Clin Auton Res. 1993. PMID: 8477180 Clinical Trial.
-
Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease.Thorax. 1998 Sep;53(9):803-8. doi: 10.1136/thx.53.9.803. Thorax. 1998. PMID: 10319066 Free PMC article. Review. No abstract available.
-
Periodic treatment regimens with inhaled steroids in asthma or chronic obstructive pulmonary disease. Is it possible?JAMA. 1995 Jul 12;274(2):161-4. doi: 10.1001/jama.274.2.161. JAMA. 1995. PMID: 7596005 Clinical Trial.
-
[Effect of vaporizing high doses of ipratropium bromide on lung ventilation in patients with chronic obstructive pulmonary disease and bronchial asthma].Pneumonol Alergol Pol. 1994;62(1-2):75-9. Pneumonol Alergol Pol. 1994. PMID: 8075617 Polish.
-
Airway inflammation in asthma and chronic obstructive pulmonary disease with special emphasis on the antigen-presenting dendritic cell: influence of treatment with fluticasone propionate.Clin Exp Allergy. 1999 Jun;29 Suppl 2:116-24. doi: 10.1046/j.1365-2222.1999.00020.x. Clin Exp Allergy. 1999. PMID: 10421834 Review.
Cited by
-
Antibacterial treatment in exacerbations of chronic obstructive pulmonary disease. Pitfalls in study design and evaluation.Pharm Weekbl Sci. 1989 Aug 25;11(4):128-31. doi: 10.1007/BF01987957. Pharm Weekbl Sci. 1989. PMID: 2677984 Review.